Trends in mortality involving both chronic lower respiratory disease and type 2 diabetes mellitus in the United States, 1999–2024: a CDC WONDER analysis

Abstract Background Chronic lower respiratory disease (CLRD) and type 2 diabetes mellitus (T2DM) are among the leading causes of death in the United States (US). CLRD and T2DM frequently coexist and share overlapping risk factors, including obesity, a sedentary lifestyle, systemic inflammation, and socioeconomic disadvantage, which can worsen outcomes. Methods Serial cross-sectional mortality analysis using death certificates sourced from the CDC WONDER database for the years 1999–2024 was conducted. Deaths among adults aged ≥ 25 years with both CLRD (ICD-10 codes J40–J47) and T2DM (ICD-10 codes E11.0–E11.9) listed anywhere on the death certificate were included. Age-adjusted mortality rates (AAMRs) per 100,000 persons were standardized to the 2000 US standard population. Annual percentage changes (APCs) and average annual percentage changes (AAPCs) were estimated using Joinpoint regression, with stratification by sex, race/ethnicity, census region, age group, and urbanization. Results From 1999 to 2024, of 326,655 deaths, AAMR rose from 2.65 (95% CI 2.57–2.73) to 7.92 (95% CI 7.82–8.02) per 100,000 (AAPC 4.14%; 95% CI 2.88–5.42; P < 0.001). AAMRs rose in women (2.09 to 6.54; AAPC 4.32%; P < 0.001) and men (3.60 to 9.75; AAPC 3.79%; P < 0.001). By age, the steepest rise was in adults aged 45–64 years (1.03 to 3.49; AAPC 4.85%; 95% CI 3.21-6.50; P < 0.001), followed by those aged ≥65 years (11.71 to 34.13; AAPC 4.04%; P < 0.001); the rise in adults aged 25–44 years was not significant (AAPC 3.47%, 2000–2024; P = 0.141). Rates rose in all racial and ethnic groups, most steeply in non-Hispanic Black adults (2.19 to 8.00; AAPC 4.56%; 95% CI 2.21-6.98; P < 0.001). Among census regions, the West had the steepest rise (2.31 to 9.55; AAPC 5.84%; 95% CI 4.45-7.25; P < 0.001), and non-metropolitan areas had higher AAMRs than metropolitan areas (AAPC 5.72% vs. 5.23%; both P < 0.001; 1999-2020). California had the highest death count; the highest AAMRs were in West Virginia in 1999–2020 (11.46) and Wyoming in 2021–2024 (19.16); and decedent's home was the most common place of death (33.2% in 1999-2020; 42.4% in 2021-2024). Conclusions Mortality involving both CLRD and type 2 DM rose substantially; rates were highest among older adults, men, and non-metropolitan residents. These findings support the evaluation of coordinated pulmonary and metabolic care in these groups; however, causal inference is limited.

Authors

Institutions

Publication Details

Journal
Diabetology & Metabolic Syndrome
Published
2026-11-15
DOI
https://doi.org/10.1186/s13098-026-02347-1
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Trends in mortality involving both chronic lower respiratory disease and type 2 diabetes mellitus in the United States, 1999–2024: a CDC WONDER analysis

Muhammad Atif Mazhar, Lata Kumari, Hekmat Yousef Al‐Akash, Vishan Das et al.
Diabetology & Metabolic Syndrome
Chronic Obstructive Pulmonary Disease (COPD) Research
article

Trends in mortality involving both chronic lower respiratory disease and type 2 diabetes mellitus in the United States, 1999–2024: a CDC WONDER analysis

Muhammad Atif Mazhar, Lata Kumari, Hekmat Yousef Al‐Akash, Vishan Das, Danish Kumar, Mohammad Usman Khan, Zaitoon Hanif, Muhammad Mubashir Shaikh, Fatima Eltayeb Elsiddig Mohammed, Ajay Kumar
article en

Abstract

Abstract Background Chronic lower respiratory disease (CLRD) and type 2 diabetes mellitus (T2DM) are among the leading causes of death in the United States (US). CLRD and T2DM frequently coexist and share overlapping risk factors, including obesity, a sedentary lifestyle, systemic inflammation, and socioeconomic disadvantage, which can worsen outcomes. Methods Serial cross-sectional mortality analysis using death certificates sourced from the CDC WONDER database for the years 1999–2024 was conducted. Deaths among adults aged ≥ 25 years with both CLRD (ICD-10 codes J40–J47) and T2DM (ICD-10 codes E11.0–E11.9) listed anywhere on the death certificate were included. Age-adjusted mortality rates (AAMRs) per 100,000 persons were standardized to the 2000 US standard population. Annual percentage changes (APCs) and average annual percentage changes (AAPCs) were estimated using Joinpoint regression, with stratification by sex, race/ethnicity, census region, age group, and urbanization. Results From 1999 to 2024, of 326,655 deaths, AAMR rose from 2.65 (95% CI 2.57–2.73) to 7.92 (95% CI 7.82–8.02) per 100,000 (AAPC 4.14%; 95% CI 2.88–5.42; P < 0.001). AAMRs rose in women (2.09 to 6.54; AAPC 4.32%; P < 0.001) and men (3.60 to 9.75; AAPC 3.79%; P < 0.001). By age, the steepest rise was in adults aged 45–64 years (1.03 to 3.49; AAPC 4.85%; 95% CI 3.21-6.50; P < 0.001), followed by those aged ≥65 years (11.71 to 34.13; AAPC 4.04%; P < 0.001); the rise in adults aged 25–44 years was not significant (AAPC 3.47%, 2000–2024; P = 0.141). Rates rose in all racial and ethnic groups, most steeply in non-Hispanic Black adults (2.19 to 8.00; AAPC 4.56%; 95% CI 2.21-6.98; P < 0.001). Among census regions, the West had the steepest rise (2.31 to 9.55; AAPC 5.84%; 95% CI 4.45-7.25; P < 0.001), and non-metropolitan areas had higher AAMRs than metropolitan areas (AAPC 5.72% vs. 5.23%; both P < 0.001; 1999-2020). California had the highest death count; the highest AAMRs were in West Virginia in 1999–2020 (11.46) and Wyoming in 2021–2024 (19.16); and decedent's home was the most common place of death (33.2% in 1999-2020; 42.4% in 2021-2024). Conclusions Mortality involving both CLRD and type 2 DM rose substantially; rates were highest among older adults, men, and non-metropolitan residents. These findings support the evaluation of coordinated pulmonary and metabolic care in these groups; however, causal inference is limited.

Diabetology & Metabolic Syndrome
Aga Khan University (PK), Liaquat University of Medical & Health Sciences (PK), Alfaisal University (SA), Applied Science Private University (JO), Jinnah Sindh Medical University (PK)
Chronic Obstructive Pulmonary Disease (COPD) Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon